Medtronic, a global leader in healthcare technology, today announced U.S. FDA approval for the Onyx™ 12 Liquid Embolic System (LES). Onyx 12 LES is now indicated for embolization of middle meningeal artery (MMA) as an adjunct to surgery for the treatment of symptomatic subacute or chronic subdural hematoma (SDH).
[...]
This is an abstract of the document. To keep reading, click here and get access to the original version.